Many new experts join DRA – our international expertise is increasing further

News • 28.03.2020

The year has started at a hectic pace. We have recruited some excellent candidates to strengthen our expertise.

Jussi Jalonen, Master of Pharmaceutical Development, joins both our regulatory services and pharmaceutical and chemical services teams. Jussi has several years of experience in working with regulatory affairs at LEO Pharma’s headquarters in Denmark, where he participated in integration projects following portfolio acquisitions. Jussi was also responsible for quality documentation and the company’s global CMC strategy.

Jonna Hautala, M.Sc. (Pharm), who has previously worked as a pharmacovigilance expert at a consulting company in Prague, has joined our pharmacovigilance team.

Sari Salokangas. B.Sc. (Pharm), has started in the regulatory services team. Sari has more than 10 years of experience or working as a marketing authorisations coordinator at Vitabalans. In this post she gained extensive experience in regulatory affairs in Europe.

Sari Salokangas (left), Jonna Hautala, Stina Kettunen and Jussi Jalonen

Stina Kettunen, health economist, has been appointed to the Market Access team. Stiina’s degree included a period of internship which she did at DRA, and now she has returned to the team to help prepare price and reimbursement applications and to create and localize health economics models.

We warmly welcome our new health professionals to the team!